Please assess the completion status of the following clinical trial:

Trial Title: Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- Clinical diagnosis of multifocal motor neuropathy, supported by electrophysiological findings~Exclusion Criteria:~* Other severe medical conditions~* Pregnancy and lactation~* Anti-coagulation therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Subcutaneous Ig given twice a week.
- 2 (Type: ACTIVE_COMPARATOR): Intravenous Ig

Based on this trial design, predict the completion outcome and termination type (if applicable).